Xylometazoline

# Xylometazoline ## Overview - **Classification**: Alpha-adrenergic agonist, Nasal Decongestant (sympathomimetic) - **Mechanism**: Acts directly on alpha-adrenergic receptors in the nasal mucosa, causing vasoconstriction of arterioles, leading to decreased blood flow and reduced swelling of nasal membranes. ## Primary Indications 1. **Nasal Congestion** - Due to common cold, sinusitis, or allergic rhinitis. 2. **Facilitate Rhinoscopy** - To shrink nasal mucosa before examination. 3. **Adjuvant in Otitis Media** - To improve Eustachian tube patency. ## Adult Dosing ### Standard Dosing **Nasal Congestion** - **Dose**: **1-2 sprays** or **2-4 drops** of **0.1%** solution into each nostril. - **Frequency**: Every 8-10 hours, up to **3 times daily**. - **Route**: Intranasal. - **Duration**: Do not use for more than **3-5 consecutive days**. ### Dose Adjustments - **Renal Impairment**: Not applicable for topical nasal administration. - **Hepatic Impairment**: Not applicable for topical nasal administration. - **Elderly Patients**: Use with caution due to potential for systemic absorption and increased sensitivity to sympathomimetics; monitor for cardiovascular effects. ## Pediatric Dosing ### Neonates (0-28 days) - **Dose**: **Contraindicated**. - **Special Notes**: Risk of systemic absorption leading to serious adverse effects (e.g., CNS depression, bradycardia, coma). ### Infants (1-12 months) - **Dose**: **Contraindicated**. - **Special Notes**: Risk of systemic absorption leading to serious adverse effects. ### Children (2-11 years) - **Indication**: Nasal Congestion - **Dose**: **1 spray** of **0.05%** solution into each nostril. - **Frequency**: 1-3 times daily. - **Maximum**: Do not exceed **3 doses** per day. - **Duration**: Do not use for more than **3-5 consecutive days**. - **Special Notes**: Not recommended for children <2 years old. Use pediatric specific formulation (**0.05%** solution). ### Adolescents (12-18 years) - **Indication**: Nasal Congestion - **Dose**: **1-2 sprays** or **2-4 drops** of **0.1%** solution into each nostril. - **Frequency**: Every 8-10 hours, up to **3 times daily**. - **Maximum**: Do not exceed **3 doses** per day. - **Duration**: Do not use for more than **3-5 consecutive days**. - **Special Notes**: Use adult strength (**0.1%** solution). ## Safety Information ### Contraindications - **Absolute**: Transsphenoidal hypophysectomy or other surgery exposing dura mater. - **Absolute**: Narrow-angle glaucoma. - **Absolute**: Rhinitis sicca (dry nasal mucosa). - **Absolute**: Concomitant use with MAOIs or within 14 days of MAOI discontinuation. - **Absolute**: Children under **2 years** of age. ### Common Adverse Effects - **Common (1-10%)**: Nasal burning or stinging, dryness of nasal mucosa. - **Common (1-10%)**: Sneezing, local irritation. - **Serious but Rare**: Rebound congestion (rhinitis medicamentosa) with prolonged use. - **Serious but Rare**: Systemic effects with excessive use (e.g., headache, palpitation, hypertension, tachycardia, insomnia, anxiety), especially in children. ### Key Drug Interactions - **Monoamine Oxidase Inhibitors (MAOIs)**: Increased risk of hypertensive crisis. - **Tricyclic Antidepressants (TCAs)**: Potentiates the pressor effects, increasing risk of hypertension. - **Other Sympathomimetics**: Increased risk of systemic adverse effects (e.g., cardiovascular stimulation). ## Monitoring & Follow-up - **Before Treatment**: Assess for contraindications (e.g., recent MAOI use, specific surgeries). - **During Treatment**: Monitor for symptom improvement and duration of use. - **Clinical Signs**: Watch for signs of rebound congestion (worsening congestion after drug wears off), nasal irritation, or systemic effects (e.g., dizziness, palpitations). ## Clinical Pearls - 💡 **Limit Duration**: Emphasize use for no more than **3-5 days** to prevent rebound congestion (rhinitis medicamentosa). - 💡 **Proper Technique**: Instruct patients on correct intranasal administration to maximize efficacy and minimize systemic absorption. - 💡 **Pediatric Caution**: Ensure correct concentration and age-appropriate dosing in children to avoid overdose and systemic toxicity. - 💡 **Avoid Sharing**: Do not share nasal sprays to prevent the spread of infections. - 💡 **First-line alternative**: Consider saline nasal sprays or washes for less severe congestion, especially for long-term use. > **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.